Stira Pharmaceuticals enables innovative sterile injectable development by providing end-to-end engineering, manufacturing, and quality operations that support product prototyping, pilot-scale runs, and scalable clinical and commercial production.
- Expertise in small molecules, peptides, oligonucleotides, and large-molecule biologics (including biosimilars)
- Liquids, suspensions, emulsions, and lyophilized products
- Primary packaging formats: vials, PFS, cartridges, and IV bags
- In-house analytical testing and stability programs, enabling fast iteration and regulatory-readiness
- Full product lifecycle support from technology transfer to validation to fill-and-finish
